The global assisted reproductive technology market size was valued at USD 14.4 billion in 2023, driven by the increasing infertility issues across the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 to achieve a value of USD 20.9 billion by 2032.
ART (Assisted Reproductive Technology) refers to fertility treatments that involve handling either eggs or embryos. Typically, ART procedures entail surgically extracting eggs from a woman's ovaries, combining them with sperm in a laboratory, and then either transferring them back to the woman's body or donating them to another woman. However, ART procedures do not involve treatments that only handle sperm (such as artificial insemination) or those where a woman takes medication to stimulate egg production without retrieving the eggs.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increasing advancements in the field by key players are expected to drive the market growth in the coming years. The expanding applications of AI in assisted reproductive technology (ART) is expected to further propel the market demand. Advanced technologies, such as precision 3D printing and advanced microscopes, are expected to assist in identifying embryos, promoting healthy pregnancy, further propelling the global assisted reproduction technology market growth.
The growth of the market is driven by the increasing initiatives by governments towards the regulation of practices as safe and effective for the people acquiring assistance from such services. For example, The Ministry of Health and Family Welfare (MoHFW) has recently rolled back the manner of retrieving oocytes and placing embryos vide Assisted Reproductive Technology Regulations in a manner where the health of no one is compromised.
The key players in the market are focusing on developing advanced healthcare systems to assist people in need of assisted reproduction technology, which is further expected to greatly influence the assisted reproduction technology market demand. Companies are integrating AI to enhance the overall experience and outcomes from the procedure to create a great impact on people and the market. For example, Alife Health wanted to reduce the overall cost of care so that more people could afford the benefits. Increasing investments by companies are also poised to drive the assisted reproductive technology market growth further. For example, Alife Health received an investment worth USD 22 million in early 2023 with which the company launched its AI platform to support and enhance clinical decision-making for IVF patients throughout the process, including during ovarian stimulation and embryo grading.
Additionally, in 2024, Alife Health plans to release two patient products that focus on providing health equity in the IVF space by helping people regardless of where they seek treatment. Such developments, initiatives, and thoughtful product launches are the major factors expected to further drive the market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Procedure
Market Breakup by Age
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market growth is significantly driven by factors such as the adoption of a sedentary lifestyle by people worldwide, which is resulting in several health issues related to reproduction. The adoption of unhealthy habits, such as eating unhealthy, smoking, and consuming alcohol are major factors responsible for such issues. Due to these health issues, people are looking towards healthcare assistance to find a solution to their problems. The medical sector is advancing rapidly and there are a few procedures available to assist such people. The rapidly advancing technology is enabling people to conceive even when they are having medical issues. Such advanced technologies are directly contributing to the increasing demand, further fuelling the global assisted reproductive technology market growth. A few examples of assisted reproductive technologies include In-vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Gamete Intrafallopian Transfer (GIFT), and Zygote Intrafallopian Transfer (ZIFT), among others.
Significant rise in the adoption of these advancing technologies for broader adoption with increasing awareness among healthcare professionals is expected to propel the market growth. The rising cases of infertility worldwide are leading to the increased adoption of assisted reproduction technology (ART), contributing significantly to the assisted reproductive technology market share. The high success rates of ART across the globe are gaining traction while providing hope to people who have some medical issues but look forward to conceiving in the coming future. The increasing disposable income among people mostly in developing countries is also contributing to the market growth.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Procedure||
|Breakup by Age||
|Breakup by Application||
|Breakup by End User||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Assisted Reproductive Technology Market Overview
3.1 Global Assisted Reproductive Technology Market Historical Value (2017-2023)
3.2 Global Assisted Reproductive Technology Market Forecast Value (2024-2032)
4 Global Assisted Reproductive Technology Market Landscape
4.1 Global Assisted Reproductive Technology: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Assisted Reproductive Technology: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Assisted Reproductive Technology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Assisted Reproductive Technology Market Segmentation
6.1 Global Assisted Reproductive Technology Market by Procedure
6.1.1 Market Overview
6.1.2 Fresh Donor
6.1.3 Fresh Nondonor
6.1.4 Frozen Donor
6.1.5 Frozen Nondonor
6.1.6 Embryo/Egg Banking
6.2 Global Assisted Reproductive Technology Market by Age
6.2.1 Market Overview
6.2.2 Women Younger Than Age 35
6.2.3 Women Older Than Age 35
6.3 Global Assisted Reproductive Technology Market by Application
6.3.1 Market Overview
6.3.2 Artificial Insemination - Intrauterine Insemination (AI-IUI)
6.3.3 Frozen Embryo Replacement (FER)
6.3.5 Ovulation Induction
6.4 Global Assisted Reproductive Technology Market by End User
6.4.1 Market Overview
6.4.3 Fertility Clinics
6.5 Global Assisted Reproductive Technology Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Assisted Reproductive Technology Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Assisted Reproductive Technology Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Assisted Reproductive Technology Market
9.1 Market Share by Country
10 Latin America Assisted Reproductive Technology Market
10.1 Market Share by Country
11 Middle East and Africa Assisted Reproductive Technology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 California Cryobank
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 Bloom Fertility Centre
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Merck KGaA
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Ferring B.V.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 FUJIFILM Irvine Scientific
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Genea Limited
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Nidacon International AB
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Celmatix Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
The market attained a value of about USD 14.4 billion in 2023, driven by the increasing adoption of a sedentary lifestyle.
The market is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 and is likely to reach a market value of USD 20.9 billion by 2032.
The increasing incidence of infertility among people due to genetic factors or a sedentary lifestyle is a major factor driving the market growth.
Rapidly advancing technological development and significantly increasing awareness about assisted reproductive technologies are among the major trends influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Women younger than age 35 and older than age 35 can benefit from this technology.
Assisted reproductive technology finds wide applications in Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), surrogacy, and ovulation induction, among others.
End users in the market are hospitals and fertility clinics, among others.
Key players involved in the market are California Cryobank, Bloom Fertility Centre, Anecova, CooperSurgical, Ferring B.V., FUJIFILM Irvine Scientific, Genea Limited, Nidacon International AB, Celmatix Inc., and Merck KGaA.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.